Mark Foley is an experienced health care executive with over 30 years in the industry. Currently, they serve as the Chief Executive Officer at Revance Therapeutics, Inc. and have held various leadership roles including Chairman, President & CEO at ZELTIQ and Managing Director at RWI Ventures. Additionally, they are a board member at Glaukos Corporation and have been involved with ULab as Chairman. Foley earned a Bachelor's Degree from the University of Notre Dame in 1987.
This person is not in the org chart
This person is not in any teams
This person is not in any offices